NEUROCRINE BIOSCIENCES INC (NBIX) Operating income 2016–2025
NEUROCRINE BIOSCIENCES INC (NBIX) annual operating income history from SEC filings — each fiscal year as reported.
$619.1MFY2025 · since FY2016: -$147.4M → $619.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $619.1M | +8.5% |
| FY2024 | $570.5M | +127.4% |
| FY2023 | $250.9M | +0.8% |
| FY2022 | $249.0M | +142.9% |
| FY2021 | $102.5M | -37.1% |
| FY2020 | $163.0M | +125.4% |
| FY2019 | $72.3M | +96.5% |
| FY2018 | $36.8M | +128.0% |
| FY2017 | -$131.4M | +10.9% |
| FY2016 | -$147.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NBIX financial trends
NBIX RevenueNBIX Net incomeNBIX Net marginNBIX Gross profitNBIX Gross marginNBIX Operating marginNBIX Operating cash flowNBIX Free cash flowNBIX Capital expendituresNBIX Return on equityNBIX Stock buybacksNBIX Dividends paidNBIX Total assetsNBIX Total liabilitiesNBIX Shareholders’ equityNBIX overview →